Cancer News and Research

Latest Cancer News and Research

Children with higher parental stress gain more weight

Parental stress is linked to weight gain in children, according to a new study from St. Michael's Hospital. The study found that children whose parents have high levels of stress have a Body Mass Index, or BMI, about 2 per cent higher than those whose parents have low levels of stress. Children with higher parental stress also gained weight at a 7 per cent higher rate during the study period than other children.

8 Dec 2013

Study explains important link between ED and development of coronary artery disease

Erectile dysfunction is caused by the inability of the artery that supplies blood to the penis to expand and contract properly. The study of this mechanism has led to a new understanding of the important link between ED and the development of coronary artery disease, and to new strategies for prevention and treatment, as described in Journal of Men's Health, a peer-reviewed publication from Mary Ann Liebert, Inc., publishers.

7 Dec 2013

Novel device may simplify monitoring of patients' response to treatment for ovarian cancer

A microchip-based device developed by Massachusetts General Hospital investigators may greatly simplify the monitoring of patients' response to treatment for ovarian cancer - the most lethal form of gynecologic cancer - and certain other malignancies.

6 Dec 2013

NYU Langone Medical Center researchers find link between gut bacteria and colorectal cancer

In one of the largest epidemiological studies of human gut bacteria and colorectal cancer ever conducted, a team of researchers at NYU Langone Medical Center has found a clear association between gut bacteria and colorectal cancer. The study, published today in the Journal of the National Cancer Institute, discovered that colorectal cancer patients had fewer beneficial bacteria and more harmful bacteria than people without the disease.

6 Dec 2013

New guide offers employers online and interactive toolkit to help support employees with cancer

A new guide developed by The National Business Group on Health and the National Comprehensive Cancer Network offers employers an online and interactive toolkit to help address the growing impact of cancer in the workplace.

6 Dec 2013

PhotoMedex terminates exclusive distribution agreement between Radiancy and Ya-Man in Japan

PhotoMedex, Inc. announced today the termination of the exclusive distribution agreement between its wholly-owned subsidiary Radiancy, Inc. and Ya-Man Ltd. for the Japanese market due to, among other things, disputed marketing expenses of approximately $1 million and the failure of Ya-Man to meet its minimum purchase obligations under the agreement.

6 Dec 2013

Silverlink, UnitedHealthcare recognized for increasing colorectal cancer screenings among minorities

Silverlink Communications, Inc., and UnitedHealthcare's program to increase colorectal cancer screenings among minority populations earned the companies a 2013 Outstanding Leadership in Population Health Award from the Care Continuum Alliance at the recent CCA Forum 2013.

6 Dec 2013

Ancon Technologies unveils new cancer-screening device

Ancon Technologies, a company devoted to finding new ways to beat cancer, recently unveiled a new cancer-screening device to the public, the NBT detector. The company's latest product aims to bring cancer detection to the next level: it uses Nanoparticle Biomarker Tagging technology to identify cancer biomarkers in exhaled air.

6 Dec 2013

C4 Imaging receives FDA clearance for Sirius MRI Marker

C4 Imaging LLC is pleased to announce U.S. Food and Drug Administration 510(k) clearance of its first product, the Sirius™ MRI Marker. The novel Positive-Signal MRI Marker will be used following treatment of prostate cancer with brachytherapy to facilitate seed localization within the prostate, utilizing a single post-implant Magnetic Resonance imaging procedure.

6 Dec 2013

MELA Sciences participates in skin cancer diagnostic workshop in Germany

MELA Sciences, Inc., designer and developer of MelaFind®, an FDA and CE Mark approved non-invasive optical device that assists dermatologists in diagnosing melanoma at its most curable stage, participated in a two-day hands-on skin cancer diagnostics workshop in Augsburg, Germany, where leading dermatologists examined "high-risk" melanoma patients with MelaFind® and also participated in an imaging devices exhibit.

6 Dec 2013

Study uncovers novel mechanism by which glioblastoma evades targeted therapies

A Ludwig Cancer Research study has uncovered an entirely novel mechanism by which glioblastoma, the most common kind of brain cancer, evades targeted therapies. Published in the current issue of the journal Science, the paper describes how GBM tumor cells essentially hide the signaling molecule targeted by such therapies, adding a layer of complexity to current models of drug resistance in cancer.

6 Dec 2013

Low vitamin D levels: Not a cause but a consequence of ill health

A comprehensive review of the evidence suggests that low vitamin D levels are not a cause but a consequence of ill health, casting strong doubt on the value of vitamin D supplements to protect against acute and chronic disorders such as cancer, cardiovascular disease, diabetes, Parkinson’s disease, and even death.

6 Dec 2013

Cancer survival rates still vary widely between European countries

Cancer survival still varies widely between European countries despite major improvements in cancer diagnosis and treatment during the first decade of the 21st century, according to the latest EUROCARE-5 reports covering over 50% of the adult and 77% of the childhood population of Europe.

6 Dec 2013

Skylight Healthcare Systems chosen as finalist in 'Fierce Innovation Awards: Healthcare Edition' program

Skylight Healthcare Systems announced today that it has been selected as a finalist in this year's Fierce Innovation Awards: Healthcare Edition, an awards program from the publisher of FierceHealthIT, FierceHealthcare, and FierceMobileHealthcare. Skylight Healthcare Systems was recognized as a finalist in the category of Population Health Management.

6 Dec 2013

Edison Investment Research's report examines long-term investment case for Bavarian Nordic

Edison Investment Research's report, An intriguing PROSPECT, examines the long-term investment case for Bavarian Nordic, which rests on key value driver Prostvac, its Phase III prostate cancer vaccine.

6 Dec 2013

Biocartis, VIB partner to develop novel MSI biomarkers for colorectal cancer

Today Biocartis and VIB announced their exclusive license agreement on a novel panel of microsatellite instability biomarkers for several cancers, in particular colorectal cancer.

From Biocartis 6 Dec 2013

Researchers update extensive toxicology database to track information about drugs toxic effects

Sometimes the cure can be worse than the disease. Pharmaceutical drugs are known for their potential side effects, and an important aspect of personalized medicine is to tailor therapies to individuals to reduce the chances of adverse events.

6 Dec 2013

State highlights: S.C. Medicaid director touts lower spending; La. targets docs who steer patients into some managed care plans; Texas set to boost Medicaid payments

South Carolina's Medicaid director says his agency is on track to spend about $250 million less this fiscal year than allotted in the state budget. Director Tony Keck told a Senate panel on Wednesday the Department of Health and Human Services is projected to spend $6.2 billion in state and federal money (Adcox, 12/4).

6 Dec 2013

Researchers discover biological mechanism that allows brain tumor cells to escape from drugs

Researchers from UCLA's Jonsson Comprehensive Cancer Center have discovered a biological mechanism that allows brain tumor cells to escape from the drugs designed to target them, resulting in drug resistance. The study was published in the December 5, 2013 online issue of Science.

6 Dec 2013

Combination drug therapy does not work well in clinical trials for cancer patients, say researchers

Medical researchers at the University of Alberta have discovered that combination drug therapy didn't work well in clinical trials for cancer patients because one drug was making the other drug ineffective.

6 Dec 2013

Cancer News and Research

Latest Cancer News and Research

Children with higher parental stress gain more weight

Study explains important link between ED and development of coronary artery disease

Novel device may simplify monitoring of patients' response to treatment for ovarian cancer

NYU Langone Medical Center researchers find link between gut bacteria and colorectal cancer

New guide offers employers online and interactive toolkit to help support employees with cancer

PhotoMedex terminates exclusive distribution agreement between Radiancy and Ya-Man in Japan

Silverlink, UnitedHealthcare recognized for increasing colorectal cancer screenings among minorities

Ancon Technologies unveils new cancer-screening device

C4 Imaging receives FDA clearance for Sirius MRI Marker

MELA Sciences participates in skin cancer diagnostic workshop in Germany

Study uncovers novel mechanism by which glioblastoma evades targeted therapies

Low vitamin D levels: Not a cause but a consequence of ill health

Cancer survival rates still vary widely between European countries

Skylight Healthcare Systems chosen as finalist in 'Fierce Innovation Awards: Healthcare Edition' program

Edison Investment Research's report examines long-term investment case for Bavarian Nordic

Biocartis, VIB partner to develop novel MSI biomarkers for colorectal cancer

Researchers update extensive toxicology database to track information about drugs toxic effects

State highlights: S.C. Medicaid director touts lower spending; La. targets docs who steer patients into some managed care plans; Texas set to boost Medicaid payments

Researchers discover biological mechanism that allows brain tumor cells to escape from drugs

Combination drug therapy does not work well in clinical trials for cancer patients, say researchers

Cancer Research - Second Edition eBook

Building quality into drug development for safer, faster medicines

How Pulp Fixin Is Turning Paper into High-Performance Sustainable Labware

A new method to measure intracellular water in biological systems

Cancer News and Research

Latest Cancer News and Research

Cancer Research - Second Edition eBook

Building quality into drug development for safer, faster medicines

How Pulp Fixin Is Turning Paper into High-Performance Sustainable Labware

A new method to measure intracellular water in biological systems

Newsletters you may be interested in